Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
INDV
$39.01
+2.07%
INDV · Indivior Pharmaceuticals, Inc.
$39.01
+0.79 (+2.07%)
At close · Aug 14
Market Cap
$4.60B
Shares
118.01M
All earnings calls
Earnings call · FY2025 Q3
Indivior Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Indivior Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$314.00M
+2.3% YoY
Diluted EPS
$0.33
+106.2% YoY
Gross margin
73.2%
-5.3 pp YoY
Net income
$42.00M
+90.9% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Oct 30, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Oct 30, 2025 · complete as-filed document